RFA #: 1212030210
|Icahn School of Medicine at Mount Sinai
|Commercialization of Valproic Acid Expanded Cord Blood Stem Cells as Allogeneic Grafts for Adults with Refractory Hematological Malignancies
|Roswell Park Cancer Institute
|Programing Hematopoetic Stem Cells for Long-Term Targeted T Cell Therapy of Patients with Relapsed Ovarian Cancer
|Weill Cornell Medical College
|Vascular Niche Platform to Expand Hematopoietic Stem and Progenitor Cells Engineered to Cure Sickle Cell Disease
Please visit the Developing Cures page for more information.